title: Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
authors.affiliation: Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: S-J
authors.initials: SJ
authors.lastname: Park
authors.forename: S W
authors.initials: SW
authors.lastname: Paik
authors.forename: M S
authors.initials: MS
authors.lastname: Choi
authors.forename: J H
authors.initials: JH
authors.lastname: Lee
authors.forename: K C
authors.initials: KC
authors.lastname: Koh
authors.forename: S J
authors.initials: SJ
authors.lastname: Kim
authors.forename: J W
authors.initials: JW
authors.lastname: Joh
authors.forename: S K
authors.initials: SK
authors.lastname: Lee
mesh_terms: D000328:Adult; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D011446:Prospective Studies; D012008:Recurrence; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007136:Immunoglobulins; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin